HEALTHCARE & MEDICARE
-
California's Blue Shield, a ZOCDOC partner to help members arrange care
Schedule an appointment can be a major challenge for patients, often forcing them to browse multiple portals, download new apps,…
Read More » -
AstraZeneca turns to CSPC Pharma again, raising $110 million to start multidrug R&D R&D PACT
Astrazeneca pre-paid $110 million to CSPC Pharmaceuticals Group to exploit AI-powered technology from China-based biotech to discover and develop new…
Read More » -
Maximize equipment uptime with predictive maintenance technology
Historically, maintenance strategies for critical systems have relied heavily on fixed schedules, called preventive maintenance. Although this is useful, it…
Read More » -
Which states have the largest private equity hospitals? – Healthcare economist
Data from the Private Equity Stakeholder Project (PESP) provides the answer. The following data are…
Read More » -
House settlement bill health care and cuts put older people at risk
New analysis from the Center for Budget and Policy Focus (CBPP) found that the House Republican budget settlement bill would…
Read More » -
Experts say
The dam is finally broken in the world of digital health. Digital health companies emerged in 2020 and 2021, but…
Read More » -
Biontech buys CUREVAC in a stock deal of $1.25B, which will also end mRNA patent dispute
Biontech, a biotech company known for its successful development of the Messenger RNA Covid-19 vaccine, is acquiring MRNA Company Curevac…
Read More » -
Employer’s Dilemma: When a fully insured plan no longer works, what’s next for an employer?
For decades, we have faced the same year’s daily routine: paying your premium. Support for renewal rate. Absorb the increase…
Read More » -
Capital RX expands to care navigation with acquisition of Amino Health
The companies announced Wednesday that pharmacy welfare manager Capital RX has acquired nursing navigation company Amine Health. New York City-based…
Read More » -
Bristol Myers Squibb pays $350 million to expand its influence in radiopharmaceuticals
Bristol Myers Squibb's efforts to diversify cancer portfolios beyond immunotherapy, which allows radiopharmaceuticals to lead to its pipeline. Now, it…
Read More »